Cementic develops lipid nanoparticles for dental disinfection and bone regeneration, specifically targeting bacterial infections in root canals and enhancing healing in orthopedic applications. Their bioceramic sealer releases antiseptic molecules at the nanoscale to eliminate pathogens, addressing complications that affect up to 60% of root canal patients.
Funding
Funding not disclosed
Founders
Product
Problem
Bacterial infections following root canal procedures and bone grafting often lead to complications, including chronic pain, tissue damage, and impaired healing, affecting a significant percentage of patients. Current treatments may not fully eradicate pathogens at the nanoscale, hindering optimal recovery and long-term success.
Solution
Cementic develops lipid nanoparticle-based solutions for dental disinfection and bone regeneration, targeting bacterial infections at the nanoscale. Their bioceramic sealer releases antiseptic molecules directly into root canals, eliminating pathogens and promoting healing. For bone regeneration, Cementic's technology focuses on immunomodulation to enhance bone growth in periodontics, oral surgery, and orthopedics. This versatile technology aims to improve patient outcomes by addressing the root causes of infection and promoting tissue regeneration.
Target Audience
The primary target audience includes dentists, oral surgeons, periodontists, and orthopedic surgeons seeking advanced solutions for infection control and tissue regeneration.
Features
- Bioceramic sealer with nanoscale antiseptic molecule release for root canal disinfection
- Immunomodulatory lipid nanoparticles to improve bone regeneration
- Targeted delivery of therapeutics to infected sites
- Broad applicability across dental, orthopedic, and surgical applications